A. Dolitzky

Primary tumors from mucosal barrier organs drive unique eosinophil infiltration patterns and clinical associations

S. Eschrich, J. Torres-Roca, A. Munitz, 2020, Oncoimmunology.

Mouse resident lung eosinophils are dependent on IL‐5

A. Munitz, M. Itan, Sharon Grisaru-Tal, 2022, Allergy.

Differential regulation of Type 1 and Type 2 mouse eosinophil activation by apoptotic cells

F. Levi-Schaffer, A. Munitz, M. Gerlic, 2022, Frontiers in Immunology.

MagRET Nanoparticles: An Iron Oxide Nanocomposite Platform for Gene Silencing from MicroRNAs to Long Noncoding RNAs.

S. Michaeli, S. Michaeli, S. Izraeli, 2015, Bioconjugate chemistry.

Metastasis-Entrained Eosinophils Enhance Lymphocyte-Mediated Antitumor Immunity

Melissa J. Davis, S. Tsuriel, S. Hediyeh-zadeh, 2021, Cancer Research.

Epithelial cell‐expressed type II IL‐4 receptor mediates eosinophilic esophagitis

Z. Halpern, M. Rothenberg, A. Munitz, 2022, Allergy.

Transcriptional Profiling of Mouse Eosinophils Identifies Distinct Gene Signatures Following Cellular Activation

N. Shomron, A. Munitz, G. Shapira, 2021, Frontiers in Immunology.

CD300b regulates intestinal inflammation and promotes repair in colitis

I. Tsarfaty, A. Munitz, H. Reichman, 2023, Frontiers in Immunology.

Antiparasitic Ointment Based on a Biocompatibile Carbon Dot Nanocomposite

S. Michaeli, A. Gedanken, V. Kumar, 2018 .

Nano-Leish-IL: A novel iron oxide-based nanocomposite drug platform for effective treatment of cutaneous leishmaniasis.

S. Michaeli, S. Kannan, Yifat Harel, 2021, Journal of controlled release : official journal of the Controlled Release Society.